Library

Home  >  Library  >  Articles

The Evolution of the global pharma industry

Working with the authorities

Drug reimbursement harmonisation in Europe

Changes at the French pharmacy

Survival strategies in contract sales organizations

Disease management opportunities in France

Optimisez votre marque personnelle

La visite médicale haute performance

How customer-centricity can increase brand preference?

Talking up sales

The brave new world of corporate marketing

Counting the cost of purchasing

Heading for change: marketing and sales trends in France

Les médicaments en libre accès : la grande illusion

Le switch : solution ou danger ?

Des stratégies opposées pour les « big pharma »

Automédication : Quel attrait pour le marché mondial ?

Should big pharma sell their OTC business?

Thin pickings in dietary supplements

How bright are the prospects for self-medication in France?

Assessing the OTC market in France

What future for the French retail generic market?

Les génériques, ce n’est plus automatique

Quelles perspectives pour les génériques?

Princeps-génériques: faut-il pactiser avec l’ennemi?

What is the value of authorized generic agreements?

Barriers to substitution

How bright is the future for generics?

Lighting fire from wet timber in French generics market

Can generics really help to curb French healthcare costs

Is the sun rising for Japanese generics?

Entering the French retail generics market

La réputation d’entreprise – Un nouvel enjeu stratégique

Le BPS, pour la ”justesse de voix”

Les marques sont-elles condamnées à mourir ?

Nosocomial Rotavirus infection in European countries

Financial requirements of immunisation programmes in developing countries: 2004-2014 perspective

The end of the back-up brands?

Making the most of maturity

Winning strategies in the French hospital market